In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

About Dr. Snyderman

  • 10 Reasons to Take Dr. Nancy Snyderman’s Advice

Myths, Truths and Tips

  • It's True ... Dessert Can Be Dinner
  • 7 Medical Myths Busted

Real Weight-Loss Facts

  • How to Figure Your Metabolic Rate
  • What Labels Really Mean
  • The Ten Most Popular Supplements
  • The Shape of Your Health
  • Sleep Yourself Slimmer
  • All Fats Are Not Created Equal
  • A Sugar by Any Other Name
  • The Latest Crop of Diet Drugs
  • How Many Carbs Do You Really Need?
  • Free Lunch? Up-and-Coming Weight-Loss Drugs
  • Expert Q&A: Heart Disease
  • Ask Dr. Synderman a Question for Her Show

Free Lunch? Up-and-Coming Weight-Loss Drugs

By: Nancy Snyderman, M.D.

weight loss pills


Eyeing a potential gold mine in the global obesity epidemic, pharmaceutical companies and universities have launched a massive drive to develop new and better diet pills. And I suspect over the next few years, we’ll have ripples of more and more diet drugs hitting the market. After all, the American public is overweight. More than two-thirds of us are obese, and we want something to fix it. Here’s a look at the next wave of diet drugs that may soon hit the market, as well as some off-label drugs used to treat obesity.

diet pills

creative crop/getty images


Available in Europe since mid- 2006 as Acomplia, rimonabant is currently under review by the FDA for prescription use here under the name Zimulti. It has been dubbed the ultimate diet pill and blockbuster drug by the press and medical community. Rimonabant works by blocking endocannabinoid receptors—present in the brain, where they affect cravings, and in fat cells, where they play a role in metabolism. These are the same receptors that bring on the “munchies” in marijuana smokers. Besides helping to control appetite, rimonabant plays a role in the breakdown of glucose and fat, which may explain why people taking the drug see improvement in a range of risk factors for heart disease and diabetes, namely their blood glucose and cholesterol readings, which can’t be explained by weight loss alone. Diabetics who took rimonabant for six months lost two and a half times more weight (15 pounds versus 6 pounds) than those taking a placebo, according to a study sponsored by Sanofi Aventis, the drug’s manufacturer. As for side effects, people who took rimonabant were slightly more likely to suffer anxiety and depression. Clinically obese people with low levels of high density lipoproteins (“good” cholesterol) and high levels of triglycerides, who have no history of anxiety or depression, are the best candidates for this drug.

page 1 of 4 | Next Page




Home  |  Health Centers  |  Health A-Z  |  Staying Healthy  |  Diet & Fitness  |  Woman & Family  |   |   |  

also on iVision:  |   |   |   |   |   |   | 

 |   |  Site Map  |   | 

Copyright (c) 2000-2009 iVision Inc. All rights reserved. The information provided on this site is intended for your general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.